Beam Therapeutics (BEAM) Financial Articles

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of... Read More

Industry: Biotechnology Sector: Healthcare

Currently in review using our new methodology check back by end of Jan 2022

Beam Therapeutics (BEAM)

Comfortable

Business Score

Financial Score

ESG Score

Report Summary

None of the business's revenue comes from Haram.
Interest is used but is not relied on to run the company.
The company has a substantial positive impact on the environment, society and governance.

What are Halal Investors' Comfort Levels?

Our Comfort Levels are based on our analysts’ latest review of a company's business, finances, and Environmental, Social and Governance (ESG) Impact. Our reports are not meant to be understood as a religious ruling (fatwa). Rather, they represent our best efforts in trying to identify whether a company is engaged in anything forbidden in Islam (haram) and to what extent. Based on our analysis, we determine our Comfort Level with investing in the company. We encourage readers to let us know if we missed anything in the comments and to voice their agreement/disagreement by leaving a thumbs up/down. Read more about our methodology.

Loading Articles...

Beam Therapeutics (BEAM) Financial Articles

Read the full report with business, financial, & ESG analysis

Members Only

What's included

Consider these free reports

Consider these instead

Get the latest reports & insights from Halal Investors. Sign up for our newsletter.